These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 6694989)

  • 1. [Determination of capping tendency in pharmaceutical active ingredients and excipients].
    Jetzer W; Leuenberger H
    Pharm Acta Helv; 1984; 59(1):2-7. PubMed ID: 6694989
    [No Abstract]   [Full Text] [Related]  

  • 2. [Technological procedure and effect of excipients on the characteristics of tablets containing small quantities of active ingredients].
    Miseta M; Pintyéné-Hódi K; Szabóné-Révész P; Selmeczi B
    Acta Pharm Hung; 1987 Mar; 57(1-2):85-92. PubMed ID: 3591346
    [No Abstract]   [Full Text] [Related]  

  • 3. Influence of dry granulation on compactibility and capping tendency of macrolide antibiotic formulation.
    Bozic DZ; Dreu R; Vrecer F
    Int J Pharm; 2008 Jun; 357(1-2):44-54. PubMed ID: 18308490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Application of new technology for effervescent tablets to different active principles].
    Joachim J; Kalantzis G; Cordoba J; Joachim G; Delonca H
    J Pharm Belg; 1985; 40(4):229-36. PubMed ID: 4067808
    [No Abstract]   [Full Text] [Related]  

  • 5. Formulation, release characteristics and bioavailability of novel monolithic hydroxypropylmethylcellulose matrix tablets containing acetaminophen.
    Cao QR; Choi YW; Cui JH; Lee BJ
    J Control Release; 2005 Nov; 108(2-3):351-61. PubMed ID: 16154656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of pharmaceutical availability of salicylic acid from tablets containing amphoteric surfactants.
    Bialik W; Jaworski E
    Pharmazie; 1990 May; 45(5):376-7. PubMed ID: 2395904
    [No Abstract]   [Full Text] [Related]  

  • 7. [Identification of excipients in tablets].
    Adam R; Bonnard J; De Herdt C; Denis E; Gloesener E; Soquet A; Van Haelen M
    J Pharm Belg; 1972; 27(4):442-56. PubMed ID: 4681076
    [No Abstract]   [Full Text] [Related]  

  • 8. [Dietetic use of red sugarbeet pigment--effervescent tablets].
    Arvouet-Grand A; Lejeune B; Pourrat A
    Pharm Acta Helv; 1990; 65(9-10):275-9. PubMed ID: 2236183
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of precirol ATO 5 on the properties of tablets.
    Sekulović D
    Pharmazie; 1987 Jan; 42(1):61-2. PubMed ID: 3575405
    [No Abstract]   [Full Text] [Related]  

  • 10. Study of the interaction between policosanol and excipients.
    Cabrera L; Uribarri E; Laguna A; Sierra R; Mederos D; González M; González V
    Boll Chim Farm; 2002; 141(2):138-42. PubMed ID: 12135162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality control of tablets by Near Infrared (NIR)-Spectroscopy.
    Petri J; Kaunzinger A; Niemöller A; Karas M
    Pharmazie; 2005 Oct; 60(10):743-6. PubMed ID: 16259120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential of carnuba wax in ameliorating brittle fracture during tableting.
    Uhumwangho MU; Okor RS; Adogah JT
    Pak J Pharm Sci; 2009 Jan; 22(1):58-61. PubMed ID: 19168422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Random mixing of drug forms with low content of active substance (2)].
    Egermann H; Pesendorfer J
    Pharm Acta Helv; 1986; 61(1):10-4. PubMed ID: 3952101
    [No Abstract]   [Full Text] [Related]  

  • 14. [Production of galenical forms of phenobarbital. In vitro control of the release of the active principle].
    Duru C; Jacob M; Puech A; Slany J; Lasserre Y
    Pharm Acta Helv; 1979; 54(2):37-43. PubMed ID: 441079
    [No Abstract]   [Full Text] [Related]  

  • 15. [Determination of excipients in pharmaceutical preparations I. Simultaneous determination of talc and aerosil in tablets].
    Varsányi E; Vida L; Paál T
    Acta Pharm Hung; 1984 Jul; 54(4):146-53. PubMed ID: 6091406
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of agglutinating and diluent excipients on the quality of Trimag tablets].
    Dumitrache M; Dorneanu V; Popovici I; Stan M; Miftode M
    Rev Med Chir Soc Med Nat Iasi; 1984; 88(1):145-7. PubMed ID: 6545960
    [No Abstract]   [Full Text] [Related]  

  • 17. [Release of the active agent from matrix tablets with mastix as the base substance].
    Georgarakis M; Georgakopoulos PP
    Pharmazie; 1984 Mar; 39(3):186-7. PubMed ID: 6728892
    [No Abstract]   [Full Text] [Related]  

  • 18. A rotating disk method to study the influence of binding agents on the dissolution rate.
    Nicklasson M; Brodin A
    Acta Pharm Suec; 1982; 19(2):119-26. PubMed ID: 7102350
    [No Abstract]   [Full Text] [Related]  

  • 19. Calcium sulphate dihydrate: an useful excipient for tablets containing labile actives.
    Eyjolfsson R
    Pharmazie; 2004 Sep; 59(9):725-6. PubMed ID: 15497759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of the SeDeM Diagram and a new mathematical equation in the design of direct compression tablet formulation.
    Suñé-Negre JM; Pérez-Lozano P; Miñarro M; Roig M; Fuster R; Hernández C; Ruhí R; García-Montoya E; Ticó JR
    Eur J Pharm Biopharm; 2008 Aug; 69(3):1029-39. PubMed ID: 18367387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.